The behavioral effects of nicotinamide adenine dinucleotide in chronic schizophrenia.
D000328:Adult; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D006801:Humans; D008297:Male; D009243:NAD / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D013608:Tablets, Enteric-Coated; D013881:Thioridazine / Q000627:therapeutic use
D010919:Placebos; D013608:Tablets, Enteric-Coated; D009243:NAD; D013881:Thioridazine